Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Breast Cancer Registration SWOG NCT00070564 - REGISTRATION Breast Cancer NCT00070564

- 17/11/21 - 1 modulo, 3 itemgroups, 26 elementi, 1 linguaggio

Itemgroups: Header, Patient characteristics, Patient Consent For Specimen Use

SOUTHWEST ONCOLOGY GROUP REGISTRATION FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer NCT00070564 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A678842F-926F-5086-E034-0003BA0B1A09

Breast Cancer Registration SWOG S0226 NCT00075764 - Registration Breast Cancer NCT00075764

- 27/09/21 - 1 modulo, 3 itemgroups, 39 elementi, 1 linguaggio

Itemgroups: Header, Patient data, Consent

Southwest Oncology Group Registration Form (S0226) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer NCT00075764 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C3225DE6-8BA0-26CF-E034-0003BA12F5E7

Registration Worksheet Breast Cancer Z1041 NCT00513292

- 20/09/21 - 1 modulo, 13 itemgroups, 81 elementi, 1 linguaggio

Itemgroups: Header Module, Patient Information, Consent, Inclusion Criteria, Exclusion Criteria, Eligibility Assessment, Method of Evaluation, Pregnancy Test, Primary Tumor Biopsy, Clinical Stage, Laboratory Values, History, Footer

Z1041: Registration Worksheet NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211E7BC7-C479-7160-E044-0003BA3F9857

Prestudy Form Advanced Breast Cancer NCT00103233

- 26/07/15 - 1 modulo, 6 itemgroups, 36 elementi, 1 linguaggio

Itemgroups: Header, PATIENT CHARACTERISTICS, MENOPAUSAL STATUS, DISEASE DESCRIPTION, PRIOR TREATMENT RELATED TO THIS CANCER, Comments

Pre-Study - SOUTHWEST ONCOLOGY GROUP Advanced Breast Cancer Prestudy Form (S0347) - 2286064v3.0 NCT00103233 SOUTHWEST ONCOLOGY GROUP Advanced Breast Cancer Prestudy Form (S0347) Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DE163996-0EFD-1EA5-E034-0003BA12F5E7

Registration Breast Cancer CALGB 40503 NCT00601900

- 25/07/15 - 1 modulo, 7 itemgroups, 44 elementi, 1 linguaggio

Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Certification Of Eligibility and Protocol Design, Initial Patient Consent For Specimen Use, Registration Information

Registration Breast Cancer CALGB 40503 NCT00601900 Registration Breast Cancer CALGB 40503 REGISTRATION WORKSHEET - 2551888v1.0 NCT00601900 CALGB 40503 REGISTRATION WORKSHEET Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24089B14-3CCA-485C-E044-0003BA3F9857

Registration Breast Cancer NSABP B-40 NCT00408408

- 04/08/15 - 1 modulo, 7 itemgroups, 38 elementi, 1 linguaggio

Itemgroups: NSABP REGISTRATION FORM, How did the patient answer the following questions on the consent form, Stratification Factors, Certification of Eligibility, Diagnostic Core Needle Biopsy, Biopsy Specimens for B-40 Correlative Studies, Baseline Clinical Tumor Assessment (Palpation Only)

A Randomized Phase III Trial of Neoadjuvant Therapy in Patients With Palpable and Operable Breast Cancer Evaluating the Effect on Pathologic Complete Response (pCR) of Adding Capecitabine or Gemcitabine to Docetaxel When Administered Before AC With or Without Bevacizumab and Correlative Science Studies Attempting to Identify Predictors of High Likelihood for pCR With Each of the Regimens Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=1B0F2A23-99E0-5C6F-E044-0003BA3F9857

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276

- 20/09/21 - 1 modulo, 4 itemgroups, 38 elementi, 1 linguaggio

Itemgroups: CALGB Information, PROTOCOL ADMINISTRATION, PATIENT DEMOGRAPHICS / PRE u TREATMENT CHARACTERISTICS, STRATIFICATION FACTORS

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-8542-227A-E034-080020C9C0E0

Registration - Phase II Breast Cancer Registration Form - 2550280v1.0 - Phase II Breast Cancer Registration Form

- 17/09/21 - 1 modulo, 6 itemgroups, 50 elementi, 1 linguaggio

Itemgroups: Registration Header, Protocol Administration, Patient Demographics / Pre-Treatment Characteristics, Certification of Eligibility, Protocol Design, Initial Patient Consent for Specimen Use

Phase II Breast Cancer Registration Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=23E49B63-1DBC-53B8-E044-0003BA3F9857

Breast Cancer NCT00041119 Registration - CALGB 40101 REGISTRATION WORKSHEET - 2670720v1.0 - CALGB 40101 REGISTRATION WORKSHEET

- 17/09/21 - 1 modulo, 6 itemgroups, 43 elementi, 1 linguaggio

Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Certification Of Eligibility and Protocol Design, Initial Patient Consent For Specimen Use, Registration Information

Cyclophosphamide and Doxorubicin (CA x 4 cycles) versus Paclitaxel (4 cycles) as Adjuvant Therapy for Breast Cancer in Women with 0-3 Positive Axillary Lymph Nodes: A 2x2 Factorial Phase III Randomized Study Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=36B8E5A6-BC9A-573E-E044-0003BA3F9857

Breast Cancer NCT00770809 Registration - CALGB 40601 REGISTRATION WORKSHEET - 2680365v1.0 - CALGB 40601 REGISTRATION WORKSHEET

- 17/09/21 - 1 modulo, 9 itemgroups, 48 elementi, 1 linguaggio

Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Certification Of Eligibility, Protocol Design, Initial Patient Consent For Specimen Use, Tissue Procurement Kit, Registration Information

CALGB 40601 REGISTRATION WORKSHEET Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=39E131B2-F4E4-13F1-E044-0003BA3F9857

Breast Cancer NCT00723294 Registration - ACOSOG-Z1072 Registration Worksheet - 2919301v1.0 - ACOSOG-Z1072 Registration Worksheet

- 09/01/15 - 1 modulo, 7 itemgroups, 54 elementi, 1 linguaggio

Itemgroups: Header Module, Eligibility Criteria, Specimen Banking Consent, Description of Primary Disease, Biopsy Data, Estrogen/Progesterone Data, Ultrasound/Mammogram

ACOSOG-Z1072 Registration Worksheet Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6EC42FC0-2010-95F5-E040-BB89AD432658

Breast Cancer Registration - S1101 Registration Worksheet Step 1 - 3252541v1.0 - S1101 Registration Worksheet Step 1

- 09/01/15 - 1 modulo, 7 itemgroups, 19 elementi, 1 linguaggio

Itemgroups: Protocol Information, SWOG PATIENT ID, DEMOGRAPHY, For SWOG Institutions:, Patient Information, Indicate how the patient answered the following questions on the consent form, Patient Eligibility

S1101 Registration Worksheet Step 1 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A7CED929-76C4-7ED1-E040-BB89AD4359CF

Keywords

Sommario

Modelli di dati selezionati